MedTrace Logo

Effects of Pneumococcal Vaccine on Nasopharyngeal Carriage

NCT01925222 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3900

Last updated 2017-03-30

No results posted yet for this study

Summary

The purpose of this study is to assess the direct effects of the ten-valent pneumococcal conjugate vaccine administered to infants on nasopharyngeal carriage at 3 to 5 years of age.

These children have been vaccinated in infancy in the cluster-randomized Finnish Invasive pneumococcal Disease (FinIP) Trial (a separate protocol reported at ClinicalTrials.gov Identifier:NCT00861380) during 2009 to 2011.

Also the indirect effect on nasopharyngeal carriage will be assessed on vaccinees' elder non-vaccinated siblings aged 5 to 9 years.

Conditions

  • Nasopharyngeal Carriage of Streptococcus Pneumoniae

Sponsors & Collaborators

Principal Investigators

  • Arto A Palmu, MD, PhD · Finnish Institute for Health and Welfare

Eligibility

Min Age
3 Years
Max Age
9 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01925222 on ClinicalTrials.gov